Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-16 Sale | 2026-03-18 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $28.09 | $280,861 | 115,211 (Direct) | View |
| 2026-02-20 Sale | 2026-02-24 4:05 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $30.1 | $1,805,766 | 492,886 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:10 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $27.83 | $278,315 | 125,211 (Direct) | View |
| 2026-02-04 Sale | 2026-02-05 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 1,779 | $32.21 | $57,295 | 105,706 (Direct) | View |
| 2026-02-04 Sale | 2026-02-05 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 1,745 | $32.19 | $56,168 | 111,226 (Direct) | View |
| 2026-02-04 Sale | 2026-02-05 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 2,994 | $32.18 | $96,359 | 105,211 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 100,087 | $32.28 | $3,230,316 | 736,486 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 6,956 | $32.12 | $223,427 | 182,485 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 7,242 | $32.12 | $232,613 | 187,971 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 7,310 | $32.12 | $234,797 | 201,463 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 12,446 | $32.87 | $409,100 | 162,657 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 4,333 | $32.12 | $139,176 | 69,240 (Direct) | View |
| 2026-02-03 Sale | 2026-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 7,175 | $32.12 | $230,461 | 175,165 (Direct) | View |
| 2026-01-23 Sale | 2026-01-27 8:25 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $30.09 | $1,805,134 | 711,038 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $27.34 | $273,420 | 120,270 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,476 | $39.74 | $98,404 | 86,311 (Direct) | View |
| 2025-12-24 Sale | 2025-12-29 9:11 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 4,980 | $40 | $199,200 | 113,013 (Direct) | View |
| 2025-12-24 Sale | 2025-12-29 9:05 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 60,000 | $40.1 | $2,406,180 | 101,443 (Direct) | View |
| 2025-12-24 Sale | 2025-12-29 9:01 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 15,000 | $42 | $630,005 | 164,787 (Direct) | View |
| 2025-12-24 Sale | 2025-12-29 8:59 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 7,402 | $40 | $296,080 | 38,233 (Direct) | View |
| 2025-12-15 Sale | 2025-12-16 4:23 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 2,910 | $36 | $104,760 | 45,635 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 4:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 20,000 | $35.01 | $700,202 | 92,083 (Direct) | View |
| 2025-11-04 Sale | 2025-11-06 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 67,115 | $36 | $2,416,140 | 77,295 (Direct) | View |
| 2025-10-31 Sale | 2025-11-04 4:05 pm | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 18,000 | $35.03 | $630,601 | 55,500 (Direct) | View |
| 2025-10-31 Sale | 2025-11-04 4:05 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 5,591 | $35 | $195,685 | 117,993 (Direct) | View |
| 2025-10-28 Sale | 2025-10-30 4:45 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 120,000 | $30.32 | $3,638,432 | 806,301 (Direct) | View |
| 2025-10-28 Sale | 2025-10-30 4:45 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 2,662 | $30 | $79,860 | 124,662 (Direct) | View |
| 2025-09-22 Sale | 2025-09-24 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $25 | $250,000 | 129,878 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 573 | $18.51 | $10,608 | 92,083 (Direct) | View |
| 2025-08-27 Sale | 2025-08-28 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 470 | $17.31 | $8,136 | 92,656 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 5:28 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 815 | $14.65 | $11,940 | 88,787 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-16 Exercise | 2026-03-18 4:05 pm | N/A 2027-01-04 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $0 | 115,211 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $19.08 | 115,211 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-24 4:05 pm | N/A 2030-01-31 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $0 | 492,886 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-24 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $15.46 | 492,886 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-19 4:10 pm | N/A 2027-01-04 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $0 | 125,211 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-19 4:10 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $19.08 | 125,211 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 417,400 | $0 | 736,486 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 103,130 | $0 | 182,485 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 103,130 | $0 | 187,971 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 95,760 | $0 | 201,463 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 73,660 | $0 | 162,657 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 35,340 | $0 | 69,240 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 9:30 pm | N/A 2036-01-31 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 92,070 | $0 | 175,165 (Direct) | View |
| 2026-01-23 Exercise | 2026-01-27 8:25 pm | N/A 2030-01-31 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $0 | 711,038 (Direct) | View |
| 2026-01-23 Exercise | 2026-01-27 8:25 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 60,000 | $15.46 | 711,038 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-21 4:05 pm | N/A 2027-01-04 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $0 | 120,270 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-21 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $19.08 | 120,270 (Direct) | View |
| 2025-12-24 Exercise | 2025-12-29 9:05 pm | N/A 2027-02-13 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 60,000 | $0 | 101,443 (Direct) | View |
| 2025-12-24 Exercise | 2025-12-29 9:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 60,000 | $20.61 | 101,443 (Direct) | View |
| 2025-12-24 Exercise | 2025-12-29 9:01 pm | N/A 2034-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 15,000 | $0 | 164,787 (Direct) | View |
| 2025-12-24 Exercise | 2025-12-29 9:01 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 15,000 | $8.93 | 164,787 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:30 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 20,000 | $16.23 | 92,083 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:30 pm | N/A 2026-05-19 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 20,000 | $0 | 92,083 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A 2028-05-10 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 61,250 | $0 | 77,295 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 17,500 | $26.88 | 77,295 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 6,250 | $8.93 | 77,295 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $27.5 | 77,295 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 10,000 | $25.25 | 77,295 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 12,500 | $22.4 | 77,295 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 4:05 pm | N/A 2026-05-17 | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 18,000 | $0 | 55,500 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 8,000 | $16.33 | 55,500 (Direct) | View |
| 2025-10-31 Exercise | 2025-11-04 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Coughlin Timothy Director | 10,000 | $17.44 | 55,500 (Direct) | View |
| 2025-11-03 Gift | 2025-11-04 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 1,078 | $0 | 117,993 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 4:45 pm | N/A 2030-01-31 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 120,000 | $0 | 806,301 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 4:45 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 120,000 | $15.46 | 806,301 (Direct) | View |
| 2025-09-23 Gift | 2025-09-24 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 891 | $0 | 127,324 (Direct) | View |
| 2025-09-22 Exercise | 2025-09-24 4:05 pm | N/A 2027-01-04 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $0 | 129,878 (Direct) | View |
| 2025-09-22 Exercise | 2025-09-24 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 10,000 | $19.08 | 129,878 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director | 26,000 | $0 | 45,250 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Squarer Ron Director | 26,000 | $0 | 54,875 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Poole Sandra Director | 26,000 | $0 | 49,500 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 26,000 | $0 | 54,875 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 26,000 | $0 | 107,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 26,000 | $0 | 77,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director | 26,000 | $0 | 75,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director | 26,000 | $0 | 48,250 (Direct) | View |